Log in to save this analysis

Save This Analysis

What do these columns mean?
Shared genes
Curated genes linked to both diseases (disease_gdp). The line below it shows how many of those are "corroborated" -- backed by 2+ independent database sources combined across both diseases, not resting on a single source's say-so.
Similarity score
Jaccard-based: shared genes ÷ the union of both diseases' entire gene sets, with a small boost from users who bookmarked both diseases. Treats both diseases symmetrically.
Overlap coefficient
Shared genes ÷ the smaller disease's own total gene count. Complements the similarity score above for asymmetric pairs -- e.g. a rare disease almost entirely "contained" in a common disease's much larger gene set scores low on Jaccard but high here.
P-value / FDR q-value
Is this gene overlap more than chance? An upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pair (the q-value is the one that accounts for testing thousands of pairs at once -- prefer it over the raw p-value).
Shared cluster
Links to a multi-disease cluster (see Disease Clusters) if both diseases of this pair were independently grouped together by that separate analysis.
ⓘ Shows only pairs whose gene overlap is too large to be down to chance (FDR q-value below 0.05). These are the rows marked ✓ sig. in the table. ⓘ Shows only pairs where both diseases also belong to the same group on the Disease Clusters page. Two separate analyses agree they're related, so the link is stronger. These are the rows with a link in the Shared cluster column.
0 selected Clear
Disease A ⇵Disease B ⇵Shared genes ⇵Similarity score ⇵Overlap coefficient ⇵P-value ⇵FDR q-value ▼ Shared cluster
Corneal astigmatism Non-small cell lung carcinoma
6 genes
Show details
BNC2(1), HERC2(1), PLCL1(1), CHSY1(1), THSD7B(1), DTNBP1(1)
0.033 0.085 1.47e-5 7.09e-5 ✓ sig. —
B-lymphoblastic leukemia/lymphoma Li-fraumeni syndrome
2 genes
Show details
2 of 2 corroborated by 2+ sources
TP53(7), CDKN2A(2)
0.087 0.400 1.44e-5 6.95e-5 ✓ sig. Cluster 3 →
B-lymphoblastic leukemia/lymphoma Urogenital neoplasms
2 genes
Show details
2 of 2 corroborated by 2+ sources
TP53(2), CDKN2A(2)
0.087 0.400 1.44e-5 6.95e-5 ✓ sig. Cluster 3 →
B-lymphoblastic leukemia/lymphoma Malt lymphoma
2 genes
Show details
FOXP1(1), IGH(1)
0.087 0.400 1.44e-5 6.95e-5 ✓ sig. —
Pfeiffer syndrome Triple negative breast cancer
2 genes
Show details
2 of 2 corroborated by 2+ sources
MDM4(2), FGFR2(8)
0.056 0.667 1.42e-5 6.85e-5 ✓ sig. —
Central nervous system disease Transient ischemic attack
2 genes
Show details
2 of 2 corroborated by 2+ sources
EPO(2), SOD2(2)
0.074 0.500 1.39e-5 6.74e-5 ✓ sig. Cluster 305 →
Anti-glomerular basement membrane disease Polyneuropathy
2 genes
Show details
HLA-DRB1(1), FCGR3A(1)
0.074 0.500 1.39e-5 6.74e-5 ✓ sig. —
Amnesia Neurodegenerative disorder
3 genes
Show details
3 of 3 corroborated by 2+ sources
APP(2), IL6(2), NGF(2)
0.053 0.167 1.39e-5 6.72e-5 ✓ sig. —
Myopathic ophthalmopathy Vogt-koyanagi-harada disease
2 genes
Show details
2 of 2 corroborated by 2+ sources
IL23R(2), PTPN22(2)
0.105 0.286 1.38e-5 6.66e-5 ✓ sig. —
Peeling skin syndrome Rheumatic disease
2 genes
Show details
2 of 2 corroborated by 2+ sources
PSORS1C1(2), CDSN(7)
0.105 0.286 1.38e-5 6.66e-5 ✓ sig. —
Basal ganglia disease Prostatic hyperplasia
2 genes
Show details
2 of 2 corroborated by 2+ sources
PRL(2), PDGFB(2)
0.105 0.286 1.38e-5 6.66e-5 ✓ sig. —
Extravasation of diagnostic and therapeutic materials Pruritus
2 genes
Show details
TAC1(1), HRH1(1)
0.105 0.286 1.38e-5 6.66e-5 ✓ sig. —
Congestive ophthalmopathy Vogt-koyanagi-harada disease
2 genes
Show details
2 of 2 corroborated by 2+ sources
IL23R(2), PTPN22(2)
0.105 0.286 1.38e-5 6.66e-5 ✓ sig. —
Branchiootorenal syndrome Congenital abnormalities
2 genes
Show details
2 of 2 corroborated by 2+ sources
EYA1(5), SIX1(6)
0.105 0.286 1.38e-5 6.66e-5 ✓ sig. Cluster 145 →
Carotid artery stenosis Osteolysis
2 genes
Show details
2 of 2 corroborated by 2+ sources
SPP1(2), TNFRSF11B(2)
0.105 0.286 1.38e-5 6.66e-5 ✓ sig. —
Keratoconus Marfan syndrome
5 genes
Show details
4 of 5 corroborated by 2+ sources
COL5A1(3), SMAD3(2), COL1A1(3), LOX(2), COL5A2(1)
0.033 0.116 1.38e-5 6.66e-5 ✓ sig. Cluster 12 →
Diabetic polyneuropathy Hypertensive heart disease
2 genes
Show details
TCF7L2(1), FTO(1)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. —
Deep vein thrombosis Disseminated intravascular coagulation
2 genes
Show details
2 of 2 corroborated by 2+ sources
SERPINC1(2), PROC(2)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. —
Pituitary hormone deficiency Septo-optic dysplasia
2 genes
Show details
2 of 2 corroborated by 2+ sources
HESX1(5), OTX2(4)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. Cluster 218 →
Osteomyelitis Tongue neoplasms
2 genes
Show details
2 of 2 corroborated by 2+ sources
TERT(2), HLA-DQB1(2)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. —
Eye disorder Synovitis
2 genes
Show details
2 of 2 corroborated by 2+ sources
COL2A1(2), POMC(2)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. Cluster 11 →
Combined pituitary hormone deficiency Septo-optic dysplasia
2 genes
Show details
2 of 2 corroborated by 2+ sources
HESX1(6), OTX2(3)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. Cluster 218 →
Aniridia Tooth abnormalities
2 genes
Show details
2 of 2 corroborated by 2+ sources
PAX6(4), PITX2(3)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. —
Arterial occlusive disease Brain edema
2 genes
Show details
2 of 2 corroborated by 2+ sources
PLAU(2), PLAT(2)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. Cluster 123 →
Atrophy Splenic disease
2 genes
Show details
2 of 2 corroborated by 2+ sources
CYP1A2(2), AHR(2)
0.111 0.222 1.36e-5 6.60e-5 ✓ sig. —

Showing 25 of 20813 pairs, sorted by significance (descending). Click a column header to sort.